Hereditary and Familial Colon Cancer
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Between 2% to 5% of all colon cancers arise in the setting of well defined inherited syndromes, including Lynch syndrome, familial adenomatous polyposis, MUTYH-associated polyposis, and certain hamartomatous polyposis conditions. Each is associated with a high risk of colon cancer. In addition to the syndromes, up to one-third of colon cancers exhibit increased familial risk, likely related to inheritance. A number of less penetrant, but possibly more frequent susceptibility genes have been identified for this level of inheritance. Clarification of predisposing genes allows for accurate risk assessment and more precise screening approaches. This review examines the colon cancer syndromes, their genetics and management, and also the common familial colon cancers with current genetic advances and screening guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T., Westman, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5950 · Cited by 876
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Genomewide Association Studies and Human Disease
Hardy, J., & Singleton, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808700 · Cited by 733
Cited by
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Self-citationSharma, R., Abbasi-Kangevari, M., Abd-Rabu, R., Abidi, H., Abu-Gharbieh, E., Acuna, J. M., Adhikari, S., Advani, S. M., Afzal, M. S., Aghaie Meybodi, M., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00044-9 · Cited by 650
Early‐onset colorectal cancer in young individuals
Mauri, G., Sartore‐Bianchi, A., Russo, A., Marsoni, S., Bardelli, A., & Siena, S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 634
Hassan, C., Quintero, E., Dumonceau, J.-M., Regula, J., Brandão, C., Chaussade, S., Dekker, E., Dinis-Ribeiro, M., Ferlitsch, M., Gimeno-García, A., et al. (2013) · Endoscopy · doi:10.1055/s-0033-1344548 · Cited by 554
Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M. T., Gad, M., Al-Husseini, M., & Saad, A. (2021) · Current Drug Targets · doi:10.2174/1389450121999201117115717 · Cited by 523
An updated Asia Pacific Consensus Recommendations on colorectal cancer screening
Sung, J. J. Y., Ng, S. C., Chan, F. K. L., Chiu, H. M., Kim, H. S., Matsuda, T., Ng, S. S. M., Lau, J. Y. W., Zheng, S., Adler, S., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-306503 · Cited by 411
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Screening and prevention of colorectal cancer
Kanth, P., & Inadomi, J. M. (2021) · BMJ · doi:10.1136/bmj.n1855 · Cited by 358
Base excision repair and cancer
Wallace, S. S., Murphy, D. L., & Sweasy, J. B. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.038 · Cited by 329
Germline Genetic Features of Young Individuals With Colorectal Cancer
Stoffel, E. M., Koeppe, E., Everett, J., Ulintz, P., Kiel, M., Osborne, J., Williams, L., Hanson, K., Gruber, S. B., & Rozek, L. S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.004 · Cited by 333
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
Gupta, S., Provenzale, D., Llor, X., Halverson, A. L., Grady, W., Chung, D. C., Haraldsdottir, S., Markowitz, A. J., Slavin Jr, T. P., Hampel, H., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0044 · Cited by 331
Genetics, diagnosis and management of colorectal cancer (Review)
DE ROSA, M., PACE, U., REGA, D., COSTABILE, V., DURATURO, F., IZZO, P., & DELRIO, P. (2015) · Oncology Reports · doi:10.3892/or.2015.4108 · Cited by 317
for the PROMISE study team, Hann, K. E. J., Freeman, M., Fraser, L., Waller, J., Sanderson, S. C., Rahman, B., Side, L., Gessler, S., & Lanceley, A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4375-8 · Cited by 314
Microbiota, Inflammation and Colorectal Cancer
Lucas, C., Barnich, N., & Nguyen, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061310 · Cited by 313
Worthley, D. L., Phillips, K. D., Wayte, N., Schrader, K. A., Healey, S., Kaurah, P., Shulkes, A., Grimpen, F., Clouston, A., Moore, D., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300348 · Cited by 308
Risk Factors Associated With Early-Onset Colorectal Cancer
Gausman, V., Dornblaser, D., Anand, S., Hayes, R. B., O'Connell, K., Du, M., & Liang, P. S. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.10.009 · Cited by 298
Molecular pathways in colorectal cancer
Al‐Sohaily, S., Biankin, A., Leong, R., Kohonen‐Corish, M., & Warusavitarne, J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07200.x · Cited by 298
Plant-derived bioactive compounds in colon cancer treatment: An updated review
Esmeeta, A., Adhikary, S., Dharshnaa, V., Swarnamughi, P., Ummul Maqsummiya, Z., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113384 · Cited by 293
Spaander, M. C. W., Zauber, A. G., Syngal, S., Blaser, M. J., Sung, J. J., You, Y. N., & Kuipers, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00432-7 · Cited by 288
Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
Migliore, L., Migheli, F., Spisni, R., & Coppedè, F. (2011) · BioMed Research International · doi:10.1155/2011/792362 · Cited by 278
Prevalence and risk factors of colorectal cancer in Asia
Wong, M. C., Ding, H., Wang, J., Chan, P. S., & Huang, J. (2019) · Intestinal Research · doi:10.5217/ir.2019.00021 · Cited by 274
Redox signaling in the gastrointestinal tract
Pérez, S., Taléns-Visconti, R., Rius-Pérez, S., Finamor, I., & Sastre, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.048 · Cited by 273
Mork, M. E., You, Y. N., Ying, J., Bannon, S. A., Lynch, P. M., Rodriguez-Bigas, M. A., & Vilar, E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4503 · Cited by 260
van Leerdam, M. E., Roos, V. H., van Hooft, J. E., Dekker, E., Jover, R., Kaminski, M. F., Latchford, A., Neumann, H., Pellisé, M., Saurin, J.-C., et al. (2019) · Endoscopy · doi:10.1055/a-0965-0605 · Cited by 258
The Immune Biology of Microsatellite-Unstable Cancer
Kloor, M., & von Knebel Doeberitz, M. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.02.004 · Cited by 245
Gastrointestinal cancers in China, the USA, and Europe
Xie, Y., Shi, L., He, X., & Luo, Y. (2021) · Gastroenterology Report · doi:10.1093/gastro/goab010 · Cited by 237
“and they together account for 5%–10% of CRC patients [29].”
BackgroundPritchard, C. C., Smith, C., Salipante, S. J., Lee, M. K., Thornton, A. M., Nord, A. S., Gulden, C., Kupfer, S. S., Swisher, E. M., Bennett, R. L., et al. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.03.002 · Cited by 204
“Mutations in APC cause familial adenomatous polyposis, Gardner’s syndrome, Turcot’s syndrome, and attenuated familial adenomatous polyposis, whereas MUTYH mutations are the cause of autosomal recessive MUTYH-associated polyposis syndrome.(3) Even with clinical guidelines such as the Revised Bethesda and Amsterdam II c…”
BackgroundThree molecular pathways model colorectal carcinogenesis in Lynch syndrome
Ahadova, A., Gallon, R., Gebert, J., Ballhausen, A., Endris, V., Kirchner, M., Stenzinger, A., Burn, J., von Knebel Doeberitz, M., Bläker, H., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31300 · Cited by 195
“Lynch syndrome and familial adenomatous polyposis (FAP) are two major inherited tumor syndromes predisposing to colorectal cancer.(1) FAP is inherited through a germline mutation in the APC gene, which, upon a second somatic”
BackgroundMismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
Li, S. K. H., & Martin, A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.003 · Cited by 191
S3-Leitlinie Kolorektales Karzinom Version 1.0 - Juni 2013 AWMF-Registernummer: 021/007OL
Pox, C., Aretz, S., Bischoff, S., Graeven, U., Hass, M., Heußner, P., Hohenberger, W., Holstege, A., Hübner, J., Kolligs, F., et al. (2013) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0033-1350264 · Cited by 179
Ocvirk, S., & O’Keefe, S. J. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0219-5 · Cited by 173
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
Meraviglia, S., Lo Presti, E., Tosolini, M., La Mendola, C., Orlando, V., Todaro, M., Catalano, V., Stassi, G., Cicero, G., Vieni, S., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1347742 · Cited by 172
Microbiota dysbiosis in select human cancers: Evidence of association and causality
Chen, J., Domingue, J. C., & Sears, C. L. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.001 · Cited by 170
“Hereditary forms only account for 3–5% of all CRC cases, while more than 95% of CRC is sporadic and mainly occurs in people older than 50 years (13, 16).”
BackgroundDevelopment and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome
Kastrinos, F., Uno, H., Ukaegbu, C., Alvero, C., McFarland, A., Yurgelun, M. B., Kulke, M. H., Schrag, D., Meyerhardt, J. A., Fuchs, C. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6120 · Cited by 169
DNA replication fidelity and cancer
Preston, B. D., Albertson, T. M., & Herr, A. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.009 · Cited by 160
Echle, A., Ghaffari Laleh, N., Quirke, P., Grabsch, H. I., Muti, H. S., Saldanha, O. L., Brockmoeller, S. F., van den Brandt, P. A., Hutchins, G. G. A., Richman, S. D., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100400 · Cited by 111
“Approximately 12% of all CRC patients have sporadic MSI/dMMR and 2%-4% of all CRC patients have MSI/dMMR due to Lynch syndrome.(6,7) Since 2019, >10 studies have shown that MSI/dMMR status can be detected from digitized pathology slides stained with hematoxylin and eosin (H&E).”
BackgroundImplications of time-series gene expression profiles of replicative senescence.
Kim, Y., Byun, H., Jee, B. A., Cho, H., Seo, Y., Kim, Y., Park, M. H., Chung, H., Woo, H. G., & Yoon, G. (2013) · Aging Cell · doi:10.1111/acel.12087 · Cited by 106
Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
Yao, Y., Suo, T., Andersson, R., Cao, Y., Wang, C., Lu, J., & Chui, E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003430.pub2 · Cited by 69
Qu, W., Zhao, Z., Chen, S., Zhang, L., Wu, D., & Chen, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.040 · Cited by 59
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
Rizzo, G., Bertotti, A., Leto, S. M., & Vetrano, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01970-2 · Cited by 51
Colorectal cancer screening in Lynch syndrome: Indication, techniques and future perspectives
Perrod, G., Rahmi, G., & Cellier, C. (2021) · Digestive Endoscopy · doi:10.1111/den.13702 · Cited by 28
CK1α overexpression correlates with poor survival in colorectal cancer
Richter, J., Kretz, A.-L., Lemke, J., Fauler, M., Werner, J.-U., Paschke, S., Leithäuser, F., Henne-Bruns, D., Hillenbrand, A., & Knippschild, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4019-0 · Cited by 28
“non-polyposis colon cancer (HNPCC/Lynch syndrome) and familial adenomatous polyposis coli (FAP) as the most common forms of hereditary CRC (reviewed in [6, 7]).”
Background
Metadata
- Authors
- Jasperson, K. W., Tuohy, T. M., Neklason, D. W., & Burt, R. W.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 138
- Issue
- 6
- Pages
- 2044-2058
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2160759097
- Cited by
- 1,312
- References
- 87
- FWCI
- 38.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.